Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

GILD holding history

Gilead Sciences, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GILD overviewAll 13F holders of GILDFull Q2 2026 holdings

Shares (Q2 2026)
238,168
Value
$30.1M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of GILD by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026238,168$30.1M0.2%−28,763−10.8%ReducedHolders
Q1 2026266,931$37.2M0.3%+29,440+12.4%AddedHolders
Q4 2025237,491$29.1M0.2%+12,516+5.6%AddedHolders
Q3 2025224,975$25.0M0.2%+4,591+2.1%AddedHolders
Q2 2025220,384$24.4M0.2%−1,576−0.7%ReducedHolders
Q1 2025221,960$24.9M0.2%+28,744+14.9%AddedHolders
Q4 2024193,216$17.8M0.2%−736−0.4%ReducedHolders
Q3 2024193,952$16.3M0.2%−989−0.5%ReducedHolders
Q2 2024194,941$13.4M0.1%−1,000−0.5%ReducedHolders
Q1 2024195,941$14.4M0.2%+9,498+5.1%AddedHolders
Q4 2023186,443$15.1M0.2%+13,667+7.9%AddedHolders
Q3 2023172,776$12.9M0.2%+1,662+1.0%AddedHolders
Q2 2023171,114$13.2M0.2%−1,241−0.7%ReducedHolders
Q1 2023172,355$14.3M0.2%+3,650+2.2%AddedHolders
Q4 2022168,705$14.5M0.2%+19,312+12.9%AddedHolders
Q3 2022149,393$9.22M0.2%+39,581+36.0%AddedHolders
Q2 2022109,812$6.79M0.1%+19,081+21.0%AddedHolders
Q1 202290,731$5.39M0.1%+4,485+5.2%AddedHolders
Q4 202186,246$6.26M0.1%+19,343+28.9%AddedHolders
Q3 202166,903$4.67M0.1%−6,062−8.3%ReducedHolders
Q2 202172,965$5.02M0.1%−36,147−33.1%ReducedHolders
Q1 2021109,112$7.05M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.